• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

基于登记的瑞典 COPD 患者队列中严重 COVID-19 的预测因素。

Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD.

机构信息

Dept of Public Health and Clinical Medicine, Division of Medicine/The OLIN-unit, Umeå University, Umeå, Sweden

COPD Center, Dept of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

Eur Respir J. 2021 Nov 11;58(5). doi: 10.1183/13993003.01920-2021. Print 2021 Nov.

DOI:10.1183/13993003.01920-2021
PMID:34413151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8581651/
Abstract

https://bit.ly/2VHZIEm

摘要

[链接]

相似文献

1
Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD.基于登记的瑞典 COPD 患者队列中严重 COVID-19 的预测因素。
Eur Respir J. 2021 Nov 11;58(5). doi: 10.1183/13993003.01920-2021. Print 2021 Nov.
2
Is a COPD patient protected against SARS-CoV-2 virus?慢性阻塞性肺疾病（COPD）患者对新型冠状病毒（SARS-CoV-2）有免疫力吗？
Infect Dis Now. 2021 Feb;51(1):98-99. doi: 10.1016/j.medmal.2020.09.015. Epub 2020 Oct 3.
3
COVID-19 and COPD: lessons beyond the pandemic.新冠病毒肺炎与慢性阻塞性肺疾病：疫情之外的教训
Am J Physiol Lung Cell Mol Physiol. 2021 Nov 1;321(5):L978-L982. doi: 10.1152/ajplung.00386.2021. Epub 2021 Sep 29.
4
Can we learn from others? The Swedish intensive care unit database for COVID-19 cases.我们能向他人学习吗？瑞典新冠肺炎病例重症监护病房数据库。
Eur J Anaesthesiol. 2021 Apr 1;38(4):331-332. doi: 10.1097/EJA.0000000000001449.
5
Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.瑞典严重 COVID-19 的预后因素负担和流行情况。
Eur J Epidemiol. 2020 May;35(5):401-409. doi: 10.1007/s10654-020-00646-z. Epub 2020 May 18.
6
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»).分析感染前合并症的背景治疗对新冠致死结局风险的影响。数据来自国际 ACTIV SARS-CoV-2 注册中心（“分析成年 SARS-CoV-2 感染者感染后慢性非传染性疾病动态”）。
Kardiologiia. 2021 Sep 30;61(9):20-32. doi: 10.18087/cardio.2021.9.n1680.
7
National outcomes and characteristics of patients admitted to Swedish intensive care units for COVID-19: A registry-based cohort study.国家重症监护室因 COVID-19 住院患者的结局和特征：基于登记的队列研究。
Eur J Anaesthesiol. 2021 Apr 1;38(4):335-343. doi: 10.1097/EJA.0000000000001459.
8
Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).严重 COVID-19 和慢性阻塞性肺疾病（COPD）患者的临床特征和结局。
Med Sci Monit. 2020 Sep 4;26:e927212. doi: 10.12659/MSM.927212.
9
Recurrent sick leave after COVID-19: investigating the first wave of the pandemic in a comprehensive Swedish registry-based study.新冠后反复请病假：基于全面瑞典注册研究调查大流行第一波疫情。
BMC Public Health. 2021 Oct 21;21(1):1914. doi: 10.1186/s12889-021-11918-y.
10
Heart failure and levels of other comorbidities in patients with chronic obstructive pulmonary disease in a Swedish population: a register-based study.瑞典人群中慢性阻塞性肺疾病患者的心力衰竭及其他合并症水平：一项基于登记册的研究。
BMC Res Notes. 2016 Apr 12;9:215. doi: 10.1186/s13104-016-2008-4.

引用本文的文献

1
Preserved ratio impaired spirometry, dysanapsis and airflow obstruction with low forced expiratory volume in 1 s in childhood asthma.在儿童哮喘中，保存率受损的肺功能检查表现为肺量计测定值降低、呼吸功能不全和气流阻塞，1秒用力呼气量低。
ERJ Open Res. 2025 Sep 8;11(5). doi: 10.1183/23120541.00023-2025. eCollection 2025 Sep.
2
Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines Reviewed.《慢性阻塞性肺疾病全球倡议（GOLD）2023年指南》述评
Open Respir Med J. 2024 Jan 10;18:e18743064279064. doi: 10.2174/0118743064279064231227070344. eCollection 2024.
3
Can the ADO Index Be Used as a Predictor of Mortality from COVID-19 in Patients with COPD?慢性阻塞性肺疾病（COPD）患者的 ADO 指数能否预测 COVID-19 死亡率？
Int J Chron Obstruct Pulmon Dis. 2024 Apr 4;19:851-858. doi: 10.2147/COPD.S440099. eCollection 2024.
4
Pre- and post-vaccination characteristics and risk factors for COVID-19 outcomes in a Swedish population-based cohort of COPD patients.瑞典一项基于人群的慢性阻塞性肺疾病（COPD）患者队列中，接种新冠疫苗前后的特征及新冠病毒病（COVID-19）结局的风险因素。
ERJ Open Res. 2023 Jun 26;9(3). doi: 10.1183/23120541.00711-2022. eCollection 2023 May.
5
Association of Area Deprivation Index With Severity of COVID-19 in Pediatric Patients: A Multisite Study of Racially and Ethnically Diverse Children.地区贫困指数与儿科 COVID-19 患者严重程度的相关性：一项针对不同种族和族裔儿童的多地点研究。
Pediatr Infect Dis J. 2023 Jun 1;42(6):e197-e200. doi: 10.1097/INF.0000000000003888. Epub 2023 Feb 22.
6
COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm.COVID-19 与心房颤动中的合并用药——斯德哥尔摩的病例对照研究。
Eur J Epidemiol. 2023 Mar;38(3):301-311. doi: 10.1007/s10654-023-00967-9. Epub 2023 Jan 28.
7
Uncontrolled asthma predicts severe COVID-19: a report from the Swedish National Airway Register.未控制的哮喘预示着 COVID-19 重症：来自瑞典气道登记处的报告。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221091183. doi: 10.1177/17534666221091183.
8
Chronic obstructive pulmonary disease and COVID-19: interrelationships.慢性阻塞性肺疾病与 COVID-19：相互关系。
Curr Opin Pulm Med. 2022 Mar 1;28(2):76-83. doi: 10.1097/MCP.0000000000000834.

本文引用的文献

1
Smoking and COVID-19 Infection and Related Mortality: A Prospective Cohort Analysis of UK Biobank Data.吸烟与新冠病毒感染及相关死亡率：基于英国生物银行数据的前瞻性队列分析
Clin Epidemiol. 2021 May 25;13:357-365. doi: 10.2147/CLEP.S300597. eCollection 2021.
2
Letter from Sweden.
Respirology. 2021 Aug;26(8):818-819. doi: 10.1111/resp.14065. Epub 2021 May 5.
3
COPD and the risk of poor outcomes in COVID-19: A systematic review and meta-analysis.慢性阻塞性肺疾病与新冠病毒病不良结局风险：一项系统评价与荟萃分析
EClinicalMedicine. 2021 Mar;33:100789. doi: 10.1016/j.eclinm.2021.100789. Epub 2021 Mar 18.
4
Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea.COPD 对 COVID-19 预后的影响：韩国一项全国范围内基于人群的研究。
Sci Rep. 2021 Feb 12;11(1):3735. doi: 10.1038/s41598-021-83226-9.
5
The Swedish National Airway Register (SNAR): development, design and utility to date.瑞典国家气道登记册（SNAR）：迄今为止的发展、设计与用途。
Eur Clin Respir J. 2020 Oct 23;7(1):1833412. doi: 10.1080/20018525.2020.1833412.
6
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.全球慢性阻塞性肺疾病诊断、管理和预防倡议。2020 年 GOLD 科学委员会关于 COVID-19 和慢性阻塞性肺疾病的报告。
Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36. doi: 10.1164/rccm.202009-3533SO.
7
A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden.基于人群的队列研究：瑞典 COVID-19 死亡的社会人口学危险因素。
Nat Commun. 2020 Oct 9;11(1):5097. doi: 10.1038/s41467-020-18926-3.
8
COVID-19 and COPD.新型冠状病毒肺炎（COVID-19）与慢性阻塞性肺疾病（COPD）。
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.02108-2020. Print 2020 Aug.
9
The effect of smoking on COVID-19 severity: A systematic review and meta-analysis.吸烟对 COVID-19 严重程度的影响：系统评价和荟萃分析。
J Med Virol. 2021 Feb;93(2):1045-1056. doi: 10.1002/jmv.26389. Epub 2020 Aug 13.
10
Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.COVID-19 患者合并症的患病率：当前文献快速综述。
Am J Infect Control. 2021 Feb;49(2):238-246. doi: 10.1016/j.ajic.2020.06.213. Epub 2020 Jul 10.